ENALAPRIL\LERCANIDIPINE: 201 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
201
Total FAERS Reports
15 (7.5%)
Deaths Reported
129
Hospitalizations
201
As Primary/Secondary Suspect
12
Life-Threatening
2
Disabilities
Active Ingredient: ENALAPRIL MALEATE\LERCANIDIPINE HYDROCHLORIDE ·
First Report: 2010 · Latest Report: 20241221
What Are the Most Common ENALAPRIL\LERCANIDIPINE Side Effects?
#1 Most Reported
Acute kidney injury
58 reports (28.9%)
#2 Most Reported
Hyperkalaemia
27 reports (13.4%)
#3 Most Reported
Lactic acidosis
20 reports (10.0%)
All ENALAPRIL\LERCANIDIPINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Acute kidney injury | 58 | 28.9% | 8 | 47 |
| Hyperkalaemia | 27 | 13.4% | 0 | 27 |
| Lactic acidosis | 20 | 10.0% | 5 | 12 |
| Drug ineffective | 18 | 9.0% | 0 | 8 |
| Fall | 18 | 9.0% | 0 | 16 |
| Vomiting | 18 | 9.0% | 0 | 12 |
| Confusional state | 16 | 8.0% | 0 | 16 |
| Blood pressure increased | 14 | 7.0% | 0 | 8 |
| Malaise | 14 | 7.0% | 0 | 11 |
| Hyponatraemia | 13 | 6.5% | 0 | 13 |
| Hypokalaemia | 11 | 5.5% | 0 | 10 |
| Hyperlactacidaemia | 10 | 5.0% | 0 | 10 |
| Hypertension | 10 | 5.0% | 0 | 1 |
| Sopor | 9 | 4.5% | 0 | 5 |
| Bradycardia | 8 | 4.0% | 2 | 7 |
| Hypotension | 8 | 4.0% | 2 | 7 |
| Supraventricular tachycardia | 8 | 4.0% | 0 | 8 |
| Syncope | 8 | 4.0% | 0 | 1 |
| Angioedema | 7 | 3.5% | 2 | 5 |
| Hypertensive crisis | 7 | 3.5% | 1 | 1 |
Who Reports ENALAPRIL\LERCANIDIPINE Side Effects? Age & Gender Data
Gender: 34.9% female, 65.1% male. Average age: 71.2 years. Most reports from: FR. View detailed demographics →
Is ENALAPRIL\LERCANIDIPINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2010 | 1 | 0 | 0 |
| 2012 | 2 | 0 | 2 |
| 2014 | 4 | 0 | 3 |
| 2015 | 12 | 3 | 7 |
| 2016 | 14 | 0 | 5 |
| 2017 | 16 | 4 | 8 |
| 2018 | 26 | 0 | 20 |
| 2019 | 37 | 6 | 20 |
| 2020 | 25 | 0 | 20 |
| 2021 | 13 | 0 | 12 |
| 2022 | 12 | 0 | 6 |
| 2023 | 9 | 0 | 9 |
| 2024 | 14 | 0 | 12 |
What Is ENALAPRIL\LERCANIDIPINE Used For?
| Indication | Reports |
|---|---|
| Hypertension | 120 |
| Product used for unknown indication | 49 |
| Acute coronary syndrome | 6 |
ENALAPRIL\LERCANIDIPINE vs Alternatives: Which Is Safer?
ENALAPRIL\LERCANIDIPINE vs ENASIDENIB
ENALAPRIL\LERCANIDIPINE vs ENBREL
ENALAPRIL\LERCANIDIPINE vs ENCORAFENIB
ENALAPRIL\LERCANIDIPINE vs ENDOXAN
ENALAPRIL\LERCANIDIPINE vs ENDOXAN BAXTER
ENALAPRIL\LERCANIDIPINE vs ENDOXAN , POUDRE POUR
ENALAPRIL\LERCANIDIPINE vs ENFORTUMAB VEDOTIN
ENALAPRIL\LERCANIDIPINE vs ENFORTUMAB VEDOTIN-EJFV
ENALAPRIL\LERCANIDIPINE vs ENFORTUMAB VEDOTIN\ENFORTUMAB VEDOTIN-EJFV
ENALAPRIL\LERCANIDIPINE vs ENFUVIRTIDE
Official FDA Label for ENALAPRIL\LERCANIDIPINE
Official prescribing information from the FDA-approved drug label.